Chemical company involved in a major legal settlement over 'forever chemicals' (PFAS).
3 AI-extracted insights from 3 sources — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Chemours in the last 30 days yet.
The 3 sources with the most insights about Chemours on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Predicted to potentially double due to its critical role in the AI supply chain.
Viewed as an AI chemical play and a 'double candidate' over the next 10 to 12 months.
Agreed to pay a share of an $875 million settlement, which highlights significant ESG risks and sets a precedent for future litigation, representing a major ongoing financial risk.
Predicted to potentially double due to its critical role in the AI supply chain.
Viewed as an AI chemical play and a 'double candidate' over the next 10 to 12 months.
Agreed to pay a share of an $875 million settlement, which highlights significant ESG risks and sets a precedent for future litigation, representing a major ongoing financial risk.
Other assets that creators frequently mention in the same content as Chemours.
The most active sources covering Chemours (CC) on Kazuha are The New York Times, @jordivisserlabs, @realvisionfinance. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 3 AI-extracted insights about Chemours (CC) from 3 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Chemours (CC) most frequently also discuss BTC, ETH, NVDA, DD, GOOGL. See the "Discussed alongside" section above for full asset pages.